ribociclib
novartis
['natalee', 'ribociclib']
the #oncoalerttoptweet day1 of #asco23 tweet by our faculty the first results of the #natalee trial investigating addition of #ribociclib to adjuvant endocrine therapy in patients with stage ii/iii hormone receptor-positive/her2-negative best 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨